SCHEMBL6229830

SCHEMBL6229830

O=C(O)NC1=CNC=CC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27657273 0.74 NFKB1 (0.38)
SCHEMBL6225603 0.72 POLB (0.54)
SCHEMBL18571420 0.70
SCHEMBL6206004 0.69 ALDH1A1 (0.32)
SCHEMBL28265319 0.68
SCHEMBL193861 0.68
SCHEMBL27546426 0.68 AKR1B1 (0.31)
SCHEMBL16718037 0.68
Hydrochloric Acid SCHEMBL27969702 0.67
Benzene SCHEMBL28096982 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111094265-B Pyrazole derivative compound and use thereof 韩美药品株式会社 2023-07-25 CN disclosed
CN-109071504-B Inhibitors of receptor interacting protein kinase 1 戴纳立制药公司 2022-03-08 CN disclosed
CN-111094265-A Pyrazole derivative compound and use thereof 韩美药品株式会社 2020-05-01 CN disclosed
CN-104507913-A Antiproliferative benzo[b]azepin-2-ones HOFFMANN LA ROCHE 2015-04-08 CN disclosed
EP-1534681-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2005-06-01 EP disclosed
WO-2004002960-A1 SUBSTITUTED QUINOLINE CCR5 RECEPTOR ANTAGONISTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-01-08 WO disclosed